In vitro studies displayed that ALBTA significantly enhanced cellular uptake by GL261 glioblastoma cells and effectively promoted endosome escape of TGF‐β siRNA, leading to a downregulation of TGF‐β expression. The gene discussed is TGFB1; the disease is glioblastoma.